J&J, Medtronic Play The Slots Before Appeals Court In Stent Patent Debate

Bare-metal stent intellectual property litigation between Johnson & Johnson/Cordis and Medtronic AVE presented before the Washington, D.C. federal appeals court May 6 hinges on the manufacturing method used to create holes in the devices

More from Archive

More from Medtech Insight